Associations of women's empowerment with neonatal, infant and under-5 mortality in low- and /middle-income countries: meta-analysis of individual participant data from 59 countries.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
2020
Historique:
received: 11 03 2019
revised: 25 06 2019
accepted: 29 06 2019
entrez: 6 3 2020
pubmed: 7 3 2020
medline: 7 3 2020
Statut: epublish

Résumé

Child survival and women's empowerment are global public health concerns and important sustainable development goals (SDGs). Low- and middle-income countries (LMICs) have the largest burden of both phenomena. The aim of this study is to investigate a measure of women's empowerment at individual and population levels and its potential associations with neonatal, infant and under-5 mortality at national and regional levels in 59 LMICs. We used pooled population-based cross-sectional surveys from 59 LMICs (n=6 12 529) conducted from 2000 to 2015 using standardised protocols. We constructed individual-level women's empowerment index (ILWEI) and population-level women's empowerment index (PLWEI) for LMICs and investigated the potential associations of these measures with neonatal, infant and under-5 mortality using two-stage random-effect individual participant data (IPD) meta-analysis. The pooled neonatal mortality rate was 24 per 1000 live births. Infant and under-5 mortality rates were 43 and 55/1000 live births, respectively. In the pooled sample, 61.6% and 19.9% of women had autonomy regarding their healthcare and household decision-making, respectively, whereas 56.0% rejected domestic violence against women for any reason. IPD meta-analysis showed that children of women with low ILWEI had a higher risk of neonatal (OR: 1.18, 95% CI 1.14 to 1.22), infant (OR: 1.12, 95% CI 1.08 to 1.17) and under-5 (OR: 1.12, 95% CI 1.07 to 1.18) mortality compared with children of high ILWEI. Similar relationships were found across most of the regions as well as between PLWEI and all the three outcomes. Women's empowerment at individual and population levels is associated with neonatal, infant and under-5 mortality in LMICs. Our study underscores the importance of women's empowerment in accelerating progress towards the attainment of the SDG targets for child survival in LMICs. Multi-sectoral and concerted efforts are necessary to eliminate preventable child mortality in these countries.

Sections du résumé

Background
Child survival and women's empowerment are global public health concerns and important sustainable development goals (SDGs). Low- and middle-income countries (LMICs) have the largest burden of both phenomena. The aim of this study is to investigate a measure of women's empowerment at individual and population levels and its potential associations with neonatal, infant and under-5 mortality at national and regional levels in 59 LMICs.
Methods
We used pooled population-based cross-sectional surveys from 59 LMICs (n=6 12 529) conducted from 2000 to 2015 using standardised protocols. We constructed individual-level women's empowerment index (ILWEI) and population-level women's empowerment index (PLWEI) for LMICs and investigated the potential associations of these measures with neonatal, infant and under-5 mortality using two-stage random-effect individual participant data (IPD) meta-analysis.
Results
The pooled neonatal mortality rate was 24 per 1000 live births. Infant and under-5 mortality rates were 43 and 55/1000 live births, respectively. In the pooled sample, 61.6% and 19.9% of women had autonomy regarding their healthcare and household decision-making, respectively, whereas 56.0% rejected domestic violence against women for any reason. IPD meta-analysis showed that children of women with low ILWEI had a higher risk of neonatal (OR: 1.18, 95% CI 1.14 to 1.22), infant (OR: 1.12, 95% CI 1.08 to 1.17) and under-5 (OR: 1.12, 95% CI 1.07 to 1.18) mortality compared with children of high ILWEI. Similar relationships were found across most of the regions as well as between PLWEI and all the three outcomes.
Conclusions
Women's empowerment at individual and population levels is associated with neonatal, infant and under-5 mortality in LMICs. Our study underscores the importance of women's empowerment in accelerating progress towards the attainment of the SDG targets for child survival in LMICs. Multi-sectoral and concerted efforts are necessary to eliminate preventable child mortality in these countries.

Identifiants

pubmed: 32133162
doi: 10.1136/bmjgh-2019-001558
pii: bmjgh-2019-001558
pmc: PMC7042599
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Pagination

e001558

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Matern Child Health J. 2016 Jan;20(1):172-186
pubmed: 26511131
Lancet. 2012 Jul 14;380(9837):80-2
pubmed: 22784540
World Dev. 2012 Mar 1;40(3):610-619
pubmed: 23637468
Soc Sci Med. 2010 Aug;71(3):634-642
pubmed: 20621752
Lancet. 2018 Apr 14;391(10129):1493-1512
pubmed: 29395272
Lancet. 2005 Mar 19-25;365(9464):1099-104
pubmed: 15781105
Glob Public Health. 2018 Jul;13(7):843-858
pubmed: 27690750
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
Nature. 2016 Jun 15;534(7607):320-2
pubmed: 27306173
N Engl J Med. 2010 Feb 18;362(7):614-23
pubmed: 20164485
Eur J Popul. 1994;10(3):203-21
pubmed: 12288310
Soc Sci Med. 2009 Sep;69(6):926-33
pubmed: 19656604
Int J Epidemiol. 2017 Oct 1;46(5):1668-1677
pubmed: 29040531
Lancet. 2008 Sep 13;372(9642):962-71
pubmed: 18790319
Lancet Glob Health. 2017 Sep;5(9):e916-e923
pubmed: 28755895
Lancet. 2016 Oct 8;388(10053):1813-1850
pubmed: 27665228
Lancet. 2014 Jul 12;384(9938):189-205
pubmed: 24853593
Soc Sci Med. 2011 Apr;72(7):1157-68
pubmed: 21411204
Lancet. 2015 Dec 5;386(10010):2275-86
pubmed: 26361942
Matern Child Nutr. 2015 Jan;11(1):1-19
pubmed: 24850533
Lancet. 2016 Oct 8;388(10053):1725-1774
pubmed: 27733285
N Engl J Med. 2013 Dec 5;369(23):2226-35
pubmed: 24304052

Auteurs

David T Doku (DT)

Department of Population and Health, University of Cape Coast, Cape Coast, Ghana.
Unit of Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, Pirkanmaa, Finland.

Zulfiqar A Bhutta (ZA)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Centre for Global Child Health, Sick Kids Foundation, Toronto, Ontario, Canada.

Subas Neupane (S)

Unit of Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, Pirkanmaa, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH